Every SEC Form 3/4/5 on record for this filer (CIK 1758507) — 1 issuer, 42 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| PBYI | PUMA BIOTECHNOLOGY, INC. | Chief Financial Officer | 2018-11-13 → 2026-02-20 | 42 | −$430,398 |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| PBYI | 2026-01-07 | Sell | 6,405 | $5.88 | $37,661 | 193,284 |
| PBYI | 2026-01-06 | Sell | 4,540 | $5.84 | $26,514 | 199,689 |
| PBYI | 2025-07-09 | Sell | 3,935 | $3.54 | $13,930 | 204,229 |
| PBYI | 2025-07-08 | Sell | 5,587 | $3.53 | $19,722 | 208,164 |
| PBYI | 2025-01-02 | Sell | 10,227 | $3.15 | $32,215 | 152,295 |
| PBYI | 2024-07-17 | Sell | 4,156 | $3.70 | $15,377 | 162,522 |
| PBYI | 2024-07-02 | Sell | 5,295 | $3.27 | $17,315 | 166,678 |
1 of 1 issuers are covered and open a security page; the rest are on file here only.
